Swiss drugmaker Novartis will start producing a genetic coronavirus vaccine this month under a deal with Massachusetts researchers. AveXis, Novartis’s gene-therapy arm, agreed to manufacture the vaccine being developed by Massachusetts Eye and Ear and Massachusetts General Hospital. Production will start in time for clinical trials that are scheduled to begin in the second half...
Novartis re-entered vaccine making on Thursday, inking a manufacturing deal with a U.S. team whose COVID-19 candidate relies on technology similar to that of the Swiss drugmaker's $2.1 million-per-patient gene therapy, Zolgensma.
Sex workers can soon get back between the sheets in Switzerland — but sports involving “close and constant contact” will remain prohibited under lockdown orders, according to a report. Swiss Health Minister Alain Berset said he believes that prostitutes are better equipped than athletes to safely return to business during the pandemic, Bloomberg reported. “There...
group KKR is preparing to inject funds into Swiss
vending machine company Selecta, which is saddled with debts and
faces a loss of business due to the coronavirus crisis, four
sources close to the matter said.
U.S. buyout group KKR is preparing to inject funds into Swiss vending machine company Selecta, which is saddled with debts and faces a loss of business due to the coronavirus crisis, four sources close to the matter said.
Novartis's gene therapy unit AveXis has signed a manufacturing agreement to produce a novel genetic COVID-19 vaccine being developed by the U.S.-based Mass General Brigham health care system, a spokeswoman for the Swiss drugmaker said on Thursday.
Travellers at Zurich's airport will encounter robot cleaners, facemask vending machines and extra room to queue for boarding when flight operations resume in earnest as cornavirus curbs ease, officials said on Thursday.
Roche plans to test if mixing its anti-inflammation drug Actemra with Gilead Sciences Inc's anti-viral treatment remdesivir works better against severe COVID-19 pneumonia than remdesivir alone, the Swiss drugmaker said on Thursday.
Swiss drugmaker Roche said on Thursday it would study its anti-inflammation drug Actemra mixed with Gilead Sciences Inc's remdesivir in hospitalised patients with severe COVID-19 pneumonia in a global trial of around 450 patients.
The court made the ruling in a case brought by an employee of an accounting firm, who claimed his company was responsible for part of his rent while he was forced to work from home, Swissinfo reported, citing the German language Tages-Anzeiger newspaper.
is a collection of country and region web sites providing local news and information to a worldwide audience.
Use InsideWorld’s headlines available on this site to access the latest stories. Or sign up today.